HCA Healthcare Appoints New Director
Ticker: HCA · Form: 8-K · Filed: Apr 30, 2024 · CIK: 860730
Sentiment: neutral
Topics: board-appointment, governance
Related Tickers: HCA
TL;DR
HCA just added the AMA President to its board.
AI Summary
HCA Healthcare, Inc. announced on April 30, 2024, that its Board of Directors appointed Dr. Samuel E. Edwards as a new director, effective April 25, 2024. Dr. Edwards, who is the President and CEO of the American Medical Association, will serve on the Nominating and Corporate Governance Committee. His appointment fills a vacancy created by the resignation of Jonathan B. Perlin.
Why It Matters
The appointment of a new director, especially one with the prominence of the AMA President, can signal strategic shifts or increased focus on industry relations for HCA Healthcare.
Risk Assessment
Risk Level: low — The filing is a routine corporate governance update regarding a board appointment and does not involve significant financial or operational changes.
Key Players & Entities
- HCA Healthcare, Inc. (company) — Registrant
- Dr. Samuel E. Edwards (person) — Newly appointed director
- American Medical Association (company) — Employer of new director
- Jonathan B. Perlin (person) — Resigned director
- April 30, 2024 (date) — Filing date
- April 25, 2024 (date) — Effective date of appointment
FAQ
Who is the new director appointed to HCA Healthcare's Board?
Dr. Samuel E. Edwards, President and CEO of the American Medical Association, was appointed as a new director.
When was Dr. Samuel E. Edwards' appointment effective?
The appointment was effective April 25, 2024.
What committee will Dr. Samuel E. Edwards serve on?
Dr. Edwards will serve on the Nominating and Corporate Governance Committee.
Why was there a vacancy on the Board of Directors?
The vacancy was created by the resignation of Jonathan B. Perlin.
What is HCA Healthcare, Inc.'s primary business?
HCA Healthcare, Inc. operates hospitals and is classified under SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC.
Filing Stats: 1,064 words · 4 min read · ~4 pages · Grade level 11.2 · Accepted 2024-04-30 16:27:55
Filing Documents
- d823649d8k.htm (8-K) — 55KB
- 0001193125-24-125204.txt ( ) — 173KB
- hca-20240425.xsd (EX-101.SCH) — 3KB
- hca-20240425_lab.xml (EX-101.LAB) — 17KB
- hca-20240425_pre.xml (EX-101.PRE) — 11KB
- d823649d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HCA HEALTHCARE, INC. By: /s/ John M. Franck II John M. Franck II Vice President – Legal and Corporate Secretary Date: April 30, 2024